Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06979219

Streamlining Radioembolization for Small HCC

Streamlining Radioembolization for HCC ≤ 5 cm With Y90 Resin Microspheres : Multicenter Prospective Registry Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
146 (estimated)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

In patients who has no sign suggesting high lung shunt fraction (TIPS, hepatic vein invasion, hepatic vein enhancement on arterial phase, dysmorphic intratumoral vessel, tumor size \< 5cm), radioembolization is performed without MAA scan with SIR-Spheres. This prospective registry will prove that the selection criteria is accurate and streamlining radioembolization is feasible and safe.

Conditions

Timeline

Start date
2025-06-10
Primary completion
2028-12-31
Completion
2029-12-31
First posted
2025-05-18
Last updated
2026-04-09

Locations

4 sites across 1 country: South Korea

Source: ClinicalTrials.gov record NCT06979219. Inclusion in this directory is not an endorsement.